Header Logo

LINA MERJANEH

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2023
267
1.710
 Why?
Hyperglycemia
2
2023
234
1.250
 Why?
Vomiting
1
2021
104
0.670
 Why?
Autoantibodies
1
2022
466
0.600
 Why?
Polycystic Ovary Syndrome
1
2019
71
0.570
 Why?
Disease Progression
3
2023
2206
0.520
 Why?
Diabetes Mellitus, Type 2
4
2024
1413
0.470
 Why?
Hypopituitarism
1
2015
19
0.470
 Why?
Diabetes Mellitus
1
2022
890
0.430
 Why?
Shock
1
2015
96
0.430
 Why?
Prediabetic State
1
2014
66
0.410
 Why?
Gastroenteritis
1
2015
316
0.390
 Why?
Insulin-Secreting Cells
1
2014
136
0.390
 Why?
Diabetes Mellitus, Type 1
3
2024
866
0.310
 Why?
Glucose Tolerance Test
2
2020
200
0.260
 Why?
Adolescent
8
2024
20982
0.240
 Why?
Acute Disease
2
2020
1153
0.220
 Why?
Young Adult
6
2024
10104
0.220
 Why?
Insulin
2
2022
1151
0.210
 Why?
Blood Glucose Self-Monitoring
1
2023
128
0.190
 Why?
Hypoglycemia
1
2022
181
0.170
 Why?
Diabetic Ketoacidosis
1
2022
164
0.160
 Why?
Menstruation Disturbances
1
2019
16
0.150
 Why?
Hyperandrogenism
1
2019
20
0.150
 Why?
Child
5
2024
26299
0.150
 Why?
Vascular Stiffness
1
2020
83
0.150
 Why?
Blood Glucose
1
2023
1104
0.150
 Why?
Glucose
1
2023
848
0.150
 Why?
Monitoring, Physiologic
1
2020
371
0.140
 Why?
Humans
11
2024
131671
0.140
 Why?
Cholesterol, LDL
1
2020
612
0.120
 Why?
Combined Modality Therapy
1
2019
1260
0.120
 Why?
Thyroid Hormones
1
2015
56
0.110
 Why?
Hydrocortisone
1
2015
224
0.110
 Why?
Cardiovascular Diseases
2
2024
2082
0.100
 Why?
Glucose Intolerance
1
2014
78
0.100
 Why?
Diagnosis, Differential
1
2019
1911
0.100
 Why?
Prevalence
1
2020
2694
0.100
 Why?
Statistics, Nonparametric
1
2014
432
0.100
 Why?
Male
5
2024
65264
0.100
 Why?
Reference Values
1
2014
692
0.100
 Why?
Hormone Replacement Therapy
1
2015
214
0.090
 Why?
Practice Guidelines as Topic
1
2019
1306
0.090
 Why?
Incidence
2
2024
3347
0.090
 Why?
Time Factors
1
2022
6279
0.090
 Why?
Age Factors
2
2020
2872
0.090
 Why?
Cross-Sectional Studies
2
2022
3834
0.080
 Why?
Sex Factors
1
2014
1346
0.080
 Why?
Adult
3
2023
31717
0.080
 Why?
Pediatrics
1
2019
1231
0.080
 Why?
Comorbidity
1
2014
1600
0.070
 Why?
Female
4
2024
71181
0.070
 Why?
Risk Assessment
1
2014
3695
0.050
 Why?
Prognosis
1
2014
4952
0.050
 Why?
Forced Expiratory Volume
1
2023
176
0.050
 Why?
Adrenal Cortex Hormones
1
2023
338
0.040
 Why?
Diabetic Angiopathies
1
2020
67
0.040
 Why?
Age of Onset
1
2020
632
0.040
 Why?
Insulin Resistance
1
2020
681
0.030
 Why?
Prospective Studies
1
2023
6494
0.020
 Why?
Anti-Bacterial Agents
1
2023
2567
0.020
 Why?
Cohort Studies
1
2020
5123
0.020
 Why?
Risk Factors
1
2024
10959
0.020
 Why?
Retrospective Studies
1
2023
17667
0.010
 Why?
United States
1
2020
11802
0.010
 Why?
MERJANEH's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_